These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 18417837

  • 1. Debate on the various anti-vascular endothelial growth factor drugs.
    Khalili MR, Hosseini H.
    Indian J Ophthalmol; 2008; 56(3):255-6; author reply 256. PubMed ID: 18417837
    [No Abstract] [Full Text] [Related]

  • 2. A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin).
    Nagpal M, Nagpal K, Nagpal PN.
    Indian J Ophthalmol; 2007; 55(6):437-9. PubMed ID: 17951900
    [Abstract] [Full Text] [Related]

  • 3. Anti-VEGF therapeutic approaches for diabetic macular edema.
    Khurana RN, Do DV, Nguyen QD.
    Int Ophthalmol Clin; 2009; 49(2):109-19. PubMed ID: 19349791
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of neovascular age-related macular degeneration with bevacizumab].
    Monzón Moreno A.
    Farm Hosp; 2006; 30(6):387-8. PubMed ID: 17298199
    [No Abstract] [Full Text] [Related]

  • 5. Anti-VEGF therapy in proliferative diabetic retinopathy.
    Abdallah W, Fawzi AA.
    Int Ophthalmol Clin; 2009; 49(2):95-107. PubMed ID: 19349790
    [No Abstract] [Full Text] [Related]

  • 6. [VEGF inhibitors in ophthalmology].
    Thys J, Dupont G, Rakic JM.
    Rev Med Liege; 2009; 64(5-6):323-6. PubMed ID: 19642468
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of intravitreal anti-VEGF injections for age-related macular degeneration.
    Jeganathan VS, Verma N.
    Curr Opin Ophthalmol; 2009 May; 20(3):223-5. PubMed ID: 19367163
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases.
    Kaiser PK.
    Am J Ophthalmol; 2006 Oct; 142(4):660-8. PubMed ID: 17011860
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical update: new treatments for age-related macular degeneration.
    Wong TY, Liew G, Mitchell P.
    Lancet; 2007 Jul 21; 370(9583):204-206. PubMed ID: 17658379
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.